Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Beata Młot

Mitomycin C and High-Dose 5-Fluorouracil With Folinic Acid as a Therapeutic Option for Heavily Pretreated Patients With Metastatic Colorectal Cancer: Prospective Phase II Trial

Oncologist

English

Heart Rhythm Disturbances After High-Dose Chemotherapy Followed by Haematopoietic Stem Cell Transplantation in a Patient With Refractory Germ Cell Cancer

Wspolczesna Onkologia

English

Related publications

Mitomycin C Plus 5-Fluorouracil Versus Plasmapheresis and the Same Chemotherapy in Metastatic Colorectal Cancer: A Prospective Randomized Trial

Journal of Cancer Research and Clinical Oncology

English

High-Dose Folinic Acid and 5-Fluorouracil Bolus and Continuous Infusion in Advanced Colorectal Cancer: Poor Response Rate in Unselected Patients

British Journal of Cancer

Cancer Research

Oncology

1995

English

Induction With Mitomycin C, Doxorubicin, Cisplatin and Maintenance With Weekly 5-Fluorouracil, Leucovorin for Treatment of Metastatic Nasopharyngeal Carcinoma: A Phase II Study

British Journal of Cancer

Cancer Research

Oncology

1999

English

A Phase II Randomised Trial of 5-Fluorouracil With or Without Interferon Alpha-2a in Advanced Colorectal Cancer

British Journal of Cancer

Cancer Research

Oncology

1996

English

Phase II Study of Gefitinib, Fluorouracil, Leucovorin, and Oxaliplatin Therapy in Previously Treated Patients With Metastatic Colorectal Cancer

Journal of Clinical Oncology

English

Oxaliplatin With Biweekly, Low Dose Leucovorin and Bolus and Continuous Infusion 5-Fluorouracil (Modified FOLFOX 4) as First-Line Therapy for Patients With Metastatic Colorectal Cancer

Cancer Research and Treatment

Cancer Research

Oncology

2004

English

Radioembolization as a Salvage Therapy for Heavily Pretreated Patients With Colorectal Cancer Liver Metastases: Factors That Affect Outcomes

Clinical Colorectal Cancer

Oncology

Gastroenterology

2015

English

Pemetrexed for Previously Treated Patients With Metastatic Gastric Cancer: A Prospective Phase II Study

British Journal of Cancer

Cancer Research

Oncology

2014

English

A Phase II Study to Evaluate Lenalidomide in Combination With Metronomic-Dose Cyclophosphamide in Patients With Heavily Pretreated Classical Hodgkin Lymphoma

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Beata Młot

Mitomycin C and High-Dose 5-Fluorouracil With Folinic Acid as a Therapeutic Option for Heavily Pretreated Patients With Metastatic Colorectal Cancer: Prospective Phase II Trial

Heart Rhythm Disturbances After High-Dose Chemotherapy Followed by Haematopoietic Stem Cell Transplantation in a Patient With Refractory Germ Cell Cancer

Related publications

Mitomycin C Plus 5-Fluorouracil Versus Plasmapheresis and the Same Chemotherapy in Metastatic Colorectal Cancer: A Prospective Randomized Trial

High-Dose Folinic Acid and 5-Fluorouracil Bolus and Continuous Infusion in Advanced Colorectal Cancer: Poor Response Rate in Unselected Patients

Induction With Mitomycin C, Doxorubicin, Cisplatin and Maintenance With Weekly 5-Fluorouracil, Leucovorin for Treatment of Metastatic Nasopharyngeal Carcinoma: A Phase II Study

A Phase II Randomised Trial of 5-Fluorouracil With or Without Interferon Alpha-2a in Advanced Colorectal Cancer

Phase II Study of Gefitinib, Fluorouracil, Leucovorin, and Oxaliplatin Therapy in Previously Treated Patients With Metastatic Colorectal Cancer

Oxaliplatin With Biweekly, Low Dose Leucovorin and Bolus and Continuous Infusion 5-Fluorouracil (Modified FOLFOX 4) as First-Line Therapy for Patients With Metastatic Colorectal Cancer

Radioembolization as a Salvage Therapy for Heavily Pretreated Patients With Colorectal Cancer Liver Metastases: Factors That Affect Outcomes

Pemetrexed for Previously Treated Patients With Metastatic Gastric Cancer: A Prospective Phase II Study

A Phase II Study to Evaluate Lenalidomide in Combination With Metronomic-Dose Cyclophosphamide in Patients With Heavily Pretreated Classical Hodgkin Lymphoma